Table 1.
P450 | Substrate | % coupling efficiency | Reference |
---|---|---|---|
| |||
1A1 | Phenacetin | 2.5 | [58] |
| |||
1A2 | Methanol | 7.5 | [58, 59] |
7-Ethoxycoumarin | 1.2 | ||
Phenacetin | 5.1 | ||
| |||
2A6 | Coumarin | 25 | [60] |
| |||
2B6 | 17-α-ethynylestradiol | 48 | [61] |
Efavirenz | 42 | ||
| |||
2C9 | (S)-flurbiprofen | 21 | [62] |
(S)-Warfarin | 4 | ||
| |||
2D6 | Bufuralol | 39 | [63, 64] |
3-Methoxyphenylethylamine | 43 | ||
4-Methoxyphenylethylamine | 42 | ||
| |||
2E1 | N-Nitrosodimethylamine | 5.6 and 59 (± b5) | [65] |
| |||
2J2 | Ebastine | 2–17 | [66] |
| |||
3A4 | Testosterone | 10–16 | [67] |
| |||
4A11 | Lauric acid | 31 | [68] |
| |||
17A1 | Progesterone | 22, 41 | [69, 70] |
17α-Hydroxyprogesterone | 1.3, 10 | ||
Pregnenolone | 97, 61 | ||
17α-Hydroxypregnenolone | 4, 44 | ||
| |||
19A1 | Androstenedione | 5 | [71] |
19-Hydroxy androstenedione | 34 | ||
19-Aldehyde androstenedione | 33 |